Navigation Links
K-State's Biosecurity Research Institute Gives Researchers the Tools Needed to Study Diseases That Cost Pig Producers Hundreds of Millions of Dollars Each Year

MANHATTAN, Kan., Aug. 13 /PRNewswire-USNewswire/ -- Porcine circovirus associated diseases cost pig producers around the world hundreds of millions of dollars each year.

That's why Kansas State University virologists Dick Hesse and Bob Rowland have been working to create new vaccines to tackle such complex diseases.

"Circovirus and its associated diseases continue to emerge around the world," Hesse said. "Both porcine reproductive and respiratory syndrome and circovirus are a worldwide problem and they continue to evolve."

Hesse and Rowland say that because these viruses continue to adapt, the quick development of effective countermeasures like vaccines is critical, as is having the facilities in which to test the vaccine in a timely fashion.

Later this month, they will begin testing their next-generation vaccine against circovirus at K-State's Biosecurity Research Institute, or BRI, in Pat Roberts Hall.

The vaccination experiment they are preparing is complex and will involve simultaneously testing several groups with porcine circovirus, porcine reproductive and respiratory syndrome, or a combination of the two. Testing vaccine efficacy against viral combinations will be crucial because that's when the most severe forms of disease occur, according to the researchers.

For the purposes of experimentation, keeping each of the groups separate also will be crucial. The BRI is designed so that research on a multitude of agents can take place in rooms adjacent to each other so there is no cross contamination.

"The viruses that we are using have some very unique properties that make containment difficult. In the field, part of the challenge presented by circovirus is that it is easily spread," Rowland said. "We have a lot of experimental groups and under normal circumstances when you are working with infectious disease, it's difficult to prevent cross contamination."

Without the BRI, Hesse and Rowland would have to go elsewhere to conduct an experiment of this scale. They said the ability to do the research at the BRI will mean that the remedies for disease can be available to producers sooner.

"The BRI has some unique capabilities and opportunities for our research," Rowland said "As a result of having access to these facilities we can accelerate our work and infectious disease research at K-State."

"This experiment is setting the stage for the future," Hesse said.

K-State's Biosecurity Research Institute is a biosafety level 3 and biosafety level 3 agriculture research facility. Research at the BRI will help scientists develop a deeper understanding of the pathogens and pests that threaten the U.S. animal- and plant-based agricultural systems so that vaccines and other countermeasures may be proactively developed.

Research at the BRI will eventually include pathogens that directly impact humans, such as brucella and various influenza strains, including H1N1.

Though circovirus and porcine reproductive and respiratory syndrome aren't human pathogens, this research will help BRI officials refine their protocols and procedures.

"The development of appropriate practices, procedures and policies are essential to performing quality research at the BRI," said Scott Rusk, director of Pat Roberts Hall. "Each incoming project will have unique requirements. This collaborative process will help us ensure the safety of personnel and promote high-quality research practices."

The existence of the BRI and the nexus of scientific expertise on animal health and disease at K-State were among the primary reasons the U.S. Department of Homeland Security chose to build the National Bio and Agro-Defense Facility in Manhattan.

SOURCE Kansas State University
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors
2. Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development
3. Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally
4. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
5. Biosafety and Biosecurity International Conference 2007 to be held in Abu Dhabi from November 12 to 14
6. Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study
7. ClinfoSource and California State University, East Bay Jointly Launch On-Line Certificate Program in Clinical Research
8. What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate
9. Yongye International Announces Expansion of Research and Development Center
10. Research breakthrough will lead to more accurate weather forecasts
11. DOE awards $377 million in funding for 46 energy frontier research centers
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... ... , ... In a new case report published today in STEM CELLS Translational ... lymphedema after being treated for breast cancer benefitted from an injection of stem cells ... this debilitating, frequent side effect of cancer treatment. , Lymphedema refers to ...
Breaking Biology Technology:
(Date:5/12/2016)... , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
Breaking Biology News(10 mins):